(Q33537687)

27 July 2017

0 references

Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease (English)

1 reference

27 July 2017

1 reference

1 reference

coronary artery disease

1 reference

1 reference

Jasleen K Duggal

1

1 reference

27 July 2017

Mukesh Singh

2

1 reference

27 July 2017

Navneet Attri

3

1 reference

27 July 2017

Param P Singh

4

1 reference

27 July 2017

Neyaz Ahmed

5

1 reference

27 July 2017

Suneet Pahwa

6

1 reference

27 July 2017

Janos Molnar

7

1 reference

27 July 2017

Sarabjeet Singh

8

1 reference

27 July 2017

Sandeep Khosla

9

1 reference

27 July 2017

Rohit Arora

10

1 reference

27 July 2017

5 March 2010

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

27 July 2017

1 reference

27 July 2017

15

1 reference

27 July 2017

2

1 reference

27 July 2017

158-166

1 reference

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

27 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Low HDL-C: a secondary target of dyslipidemia therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosc

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Gemfibrozil, nicotinic acid and combination therapy in patients with isolated hypoalphalipoproteinemia: a randomized, open-label, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Long-term benefit of high-density lipoprotein cholesterol-raising therapy with bezafibrate: 16-year mortality follow-up of the bezafibrate infarction prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Combined statin and niacin therapy remodels the high-density lipoprotein proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Extended-release niacin or ezetimibe and carotid intima-media thickness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248410361337

21 January 2018

Identifiers

DOI

10.1177/1074248410361337

1 reference

27 July 2017

1 reference